This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n9http://linked.opendata.cz/resource/drugbank/drug/DB07827/identifier/pubchem-substance/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07827/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
n14http://linked.opendata.cz/resource/drugbank/drug/DB07827/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07827/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB07827/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07827
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n8:DB07827 n11:DB07827
dcterms:title
4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID
adms:identifier
n4:10224181 n9:99444298 n12:DB07827 n13:GG1 n14:8399672
n5:IUPAC-Name
n6:271B4317-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B431D-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B431C-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4319-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B431A-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B431B-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4315-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4316-363D-11E5-9242-09173F13E4C5 n6:271B4313-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4314-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4323-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4324-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B431E-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B431F-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4321-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4320-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4322-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4329-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B432B-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B432C-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4328-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4327-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B432A-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4318-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4325-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4326-363D-11E5-9242-09173F13E4C5